Indian Regulators Warn Companies Against “Unethical Promotion” Of Drugs To Doctors
This article was originally published in PharmAsia News
MUMBAI - India's drug price regulatory body, the National Pharmaceutical Pricing Authority, has come down heavily on perpetrators of "unethical promotion of drugs" to medical practitioners, adding that such moves push up drug prices, making them unaffordable to the masses
You may also be interested in...
Indian industry pushes for self-regulation in effort to ward off new regulations.
MUMBAI - Large consignments of drug exports from India routed through the European Union are being confiscated on allegations of violation of local European patent laws. As per the EU patent laws, such exports are also termed as counterfeit drugs, experts say
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).